ONCOSEC MED INC - COM NEW (ONCS)

CUSIP: 68234L207

Q1 2019 13F Holders as of 31 Mar 2019

Type / Class
Equity / COM NEW
Total 13F shares
3,333,223
Share change
-794,068
Total reported value
$1,855,000
Price per share
$0.56
Number of holders
27
Value change
-$542,701
Number of buys
8
Number of sells
13

Quarterly Holders Quick Answers

What is CUSIP 68234L207?
CUSIP 68234L207 identifies ONCS - ONCOSEC MED INC - COM NEW in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of ONCOSEC MED INC - COM NEW (ONCS) as of Q1 2019

As of 31 Mar 2019, ONCOSEC MED INC - COM NEW (ONCS) was held by 27 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 3,333,223 shares. The largest 10 holders included VANGUARD GROUP INC, Intrinsic Edge Capital Management LLC, BlackRock Inc., GEODE CAPITAL MANAGEMENT, LLC, 683 Capital Management, LLC, NORTHERN TRUST CORP, COMMONWEALTH EQUITY SERVICES, LLC, D.A. DAVIDSON & CO., PRICE T ROWE ASSOCIATES INC /MD/, and Zurcher Kantonalbank (Zurich Cantonalbank). This page lists 27 institutional shareholders reporting positions in this security for the Q1 2019 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.